Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Video game teaches diabetic kids how to manage their disease

NCT ID NCT03520855

First seen Apr 09, 2026 · Last updated Jun 20, 2026 · Updated 10 times

Summary

This study tested whether a serious computer game (DIVE) could help children aged 10-17 with newly diagnosed type 1 diabetes learn about their condition. 78 kids played the game twice a week for at least an hour, and researchers measured their knowledge with a 50-question test. The goal was to see if the game reinforced what they learned in standard therapeutic education.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Necker Hospital

    Paris, Paris, 75015, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

serious game (DIVE software)

What this could lead to

If it works, this could show that a fun computer game helps children with type 1 diabetes learn how to manage their condition better.

What could go wrong

This is a small, completed study with only 78 participants. It tests knowledge, not direct health outcomes, so even if it works, it may not improve blood sugar control or reduce complications.

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.